跳至主要内容
临床试验/RBR-54y5wr
RBR-54y5wr招募中未知

Efficacy of vaginal monoplar focused radiofrequency, vaginal estrogenic therapy, or vaginal polyacrylic acid, for the treatment of genito urinary syndrome fo menopause (GSM): randomized clinical trial

Faculdade de Ciências Médicas da Universidade Estadual de Campinas, Unicamp0 个研究点开始时间: 2020年2月18日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
30Y 至 75Y(—)
性别
Female

入选标准

  • Menopausal women; sexually active; between 30 and 75 years; with at least one of the symptoms of SGM classified as moderate and / or severe.

排除标准

  • The explicit refusal or inability of the woman to participate in the study, and any reasons that prevent the application of the treatment;
  • BMI 35 kg / m2; Chronic renal failure; Hepatic insufficiency; Tuberculosis; Ascites and anasarca; Febrile conditions of unknown origin; History of estrogen-dependent neoplasias; Active sexually transmitted disease; Cardiovascular diseases such as thrombophlebitis, thrombosis and peripheral arterial disease); Active vaginal infection (bacterial vaginosis or candidiasis); Oncotic cytology altered in the last twelve months, such as atypical squamous cells of significance indeterminate (ASCUS), atypical squamous cells of undetermined significance can not be excluded high-grade intraepithelial lesion (ASC-H), low-grade squamous intraepithelial lesion (LSIL), and lesion
  • high-grade squamous intraepithelial (HSIL); Vaginal bleeding of unknown cause; active collagen diseases; Pelvic radiation therapy; Metal implants (pacemaker or automatic defibrillator / cardioverter, copper IUD); Not have used in the last month medications known to be impacting collagen metabolism and in the healing process, such as steroidal and nonsteroidal anti-inflammatory drugs; Do not use NSAIDs and AIES in the last month (they affect collagen metabolism and healing); Use of vaginal moisturizers in the last 6 months; Use of local estrogen therapy in the last 6 months; Use of systemic hormonal therapy in the last 6 months; Absolute contraindications to hormonal therapy, according to the Brazilian Consensus on Hormonal Therapy, 2018.

研究者

发起方
Faculdade de Ciências Médicas da Universidade Estadual de Campinas, Unicamp

相似试验